Startups
Enumeral is discovering and developing novel antibody immunotherapies that help the immune system attack diseased cells. Our unique platform allows us to identify and characterize promising new drugs relevant to cancer, infectious and inflammatory diseases, giving us the potential to positively affect millions of patients who are underserved by current therapeutic alternatives.
Overview
Location
United States, Massachusetts, Cambridge
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Montrose Capital Partners | montrosecapital.com |
Reviews 0
FAQ about Enumeral Biomedical
Who has invested in Enumeral Biomedical?
Parsers VC lists 2 investors of Enumeral Biomedical, among them Montrose Capital Partners.
Is Enumeral Biomedical still active?
Yes, Enumeral Biomedical is active.